Equity Overview
Price & Market Data
Price: $0.003
Daily Change: $0.00 / 0.00%
Range: $0.003 - $0.003
Market Cap: $477,926
Volume: 13,000
Performance Metrics
1 Week: -32.58%
1 Month: -23.08%
3 Months: -57.14%
6 Months: -67.39%
1 Year: -68.17%
YTD: -55.88%
Details
Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on commercializing value-added products in specialty therapeutic areas in Canada. The company markets and distributes ZIMED PF, a preservative-free bimatoprost prescription drug for the treatment of glaucoma. It also develops REV-0100 for the treatment of stargardt disease that is in pre-clinical trial. The company has a strategic collaboration with reVision for the development of a therapy for stargardt disease. Aequus Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada.